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Adipogenesis, or the conversion of proliferating pre-
adipocytes into nondividing adipocytes, is an im-
portant part of the vertebrate weight-maintenance
program. It is not yet understood how and when an
irreversible transition occurs into a distinct state
capable of accumulating lipid. Here, we use single-
cell fluorescence imaging to show that an all-or-
none switch is induced before lipid accumulation
occurs. Conversion begins by glucocorticoid and
cAMP signals raising C/EBPb levels above a critical
threshold, triggering three consecutive positive feed-
back loops: from PPARg to C/EBPa, then to C/EBPb,
and last to the insulin receptor. Experiments and
modeling show that these feedbacks create a robust,
irreversible transition to a terminally differentiated
state by rejecting short- and low-amplitude stimuli.
After the differentiation switch is triggered, insulin
controls fat accumulation in a graded fashion. Alto-
gether, our study introduces a regulatory motif that
locks cells in a differentiated state by engaging a
sequence of positive feedback loops.
INTRODUCTION
Adipocytes, or fat cells, are essential for human health, carrying
out critical functions including cushioning and insulating the
body and internal organs, storing up to 80%–90% of the body’s
energy, and regulating glucose homeostasis and energy metab-
olism by secreting key hormones such as leptin, adiponectin,
and TNF-a (Ahima and Flier, 2000; Rosen and Spiegelman,
2006). With the current epidemic of obesity and the strong
correlations of obesity with diabetes, cardiovascular disease,
and cancer, understanding the molecular mechanisms under-
lying adipogenesis, or the conversion of dividing preadipocytes
into nondividing, lipid-accumulating fat cells, is of great scientific
and medical interest. Many regulatory factors have been impli-
cated in adipogenesis and have been depicted in summary
diagrams (i.e., Cristancho and Lazar, 2011; Farmer, 2006;
Lowe et al., 2011). However, static diagrams are inadequate
for understanding the key steps in a dynamic and complex
process like adipogenesis. In addition, to understand if, when,976 Cell Reports 2, 976–990, October 25, 2012 ª2012 The Authorsand how a clear commitment decision is made and a cell transi-
tions irreversibly from a distinct preadipocyte state into a distinct
adipocyte state requires measurements at the single-cell level.
Such a single-cell analysis has not yet been performed during
adipogenesis.
Adipogenesis occurs over several days and can be triggered
by a number of hormonal stimuli. Several cell models have
been established to study adipogenesis in vitro (Green and
Kehinde, 1976; Wolins et al., 2006). In these models, adipogen-
esis is induced by the addition of glucocorticoid and insulin
together with different strategies to increase cAMP. Key players
in the transcriptional network controlling adipogenesis include
the transcription factors C/EBPb and C/EBPa and the nuclear
receptor PPARg, which is often described as a master regulator
because it has been shown to be both necessary and sufficient
for fat cell differentiation (Tontonoz and Spiegelman, 2008).
Expression of C/EBPb has been shown to induce the expression
of PPARg (Wu et al., 1996), most likely due to direct regulation
because C/EBP binding sites have been identified in the PPARg
promoter (Zhu et al., 1995; Fajas et al., 1997). Previous work
showed that a positive feedback exists between PPARg and
C/EBPa, and it has been suggested that this positive feedback
is important to induce a terminal differentiated state (El-Jack
et al., 1999; Rosen et al., 2002; Wu et al., 1999). However, posi-
tive feedbacks in cell regulatory systems are common, and their
function in many cases is simply to amplify a transmitted signal
(Brandman and Meyer, 2008). To trigger an irreversible decision
or bistable switch, a cooperative regulatory step is required in
addition to positive feedback. Also, in most known biological
switch mechanisms such as the oscillations in Ca2+ signaling
and the G2/M cell-cycle decision, cells rely on more than one
positive feedback (Brandman et al., 2005). Neither multiple posi-
tive feedbacks nor cooperativity in the activation steps has been
described in adipocyte differentiation.
Even the presence of multiple, cooperative positive feedbacks
does not prove that a bistable, irreversible, or differentiated state
is induced; this depends further on the specific enzymatic
parameters. To show that a bimodal state is induced, single-
cell experimental data using markers for the feedback regulators
are first needed. To then prove that such a bimodal state is irre-
versible or bistable, one has to show that the inducing signals
can be lowered or removed without losing the new differentiated
state created by these feedback regulators (Pomerening et al.,
2003; Yao et al., 2008). Finally, it has not yet been determined
whether the induction of a bistable differentiation switch occurs
independently of fat accumulation because current protocols
typically use lipid accumulation as the marker for the differenti-
ated state. These considerations provided the incentive for the
studies we pursued here to uncover the molecular mechanisms
triggering a potential irreversible bistable switch, and also to
determine whether the triggering of such a switch precedes,
coincides, or involves lipid synthesis.
To achieve this goal, we developed and applied an image-
based approach to simultaneously quantify multiple key param-
eters in thousands of single cells over the time course of
adipogenesis. Our analysis showed that the fat cell differen-
tiation process is bimodal and that a clear decision is made
early in differentiation before lipogenesis occurs. We identified
a reinforcing feedback loop from PPARg back to C/EBPb that
engages with a marked delay after a first positive feedback
between PPARg and C/EBPa. This delay is caused by a require-
ment for higher PPARg activity for the second feedback to be
triggered. We then identified a third commitment step, in which
PPARg expression is further boosted by a positive feedback
between PPARg and the insulin receptor that again engages
with a delay after the first two positive feedbacks. We used these
single-cell measurements to generate a quantitativemodel of the
differentiation decision. Together with experimental data, model
analysis showed that this consecutive feedback loop design is
uniquely suited to lock cells in a differentiated state. Thus, our
study introduces a regulatory design whereby multiple positive
feedback loops sequentially engagewith time delays to generate
a robust transition to a terminally differentiated state.
RESULTS
Single-Cell Analysis of Adipogenic Transcription Factor
Expression and Lipid Droplet Formation
To identify a potential bistable switch in the adipocyte differenti-
ation path, we developed a multiparameter, single-cell assay to
measure expression of key transcription factors and lipid droplet
content over the time course of adipogenesis in both 3T3-L1
cells, a mouse embryo-derived cultured adipocyte model (Green
andKehinde, 1976), aswell as OP9 cells, a bonemarrow-derived
adipocyte model. We and others have verified that OP9 and 3T3-
L1 cells have similar adipocyte differentiation characteristics,
although OP9 cells do differentiate faster than 3T3-L1 cells (Fig-
ures S1A and S1B; Wolins et al., 2006). OP9 cells represent late-
stage preadipocytes and thus aremore advanced in the differen-
tiation process to become adipocytes (Wolins et al., 2006).
Figure 1A shows a schematic representation of transcriptional
regulators that have been shown to control adipogenesis.
C/EBPb expression is upregulated by glucocorticoid and cAMP
(Yeh et al., 1995), and PPARg expression by C/EBPb, C/EBPa,
and insulin (Kim et al., 1998), with PPARg then driving adipogen-
esis. Adipogenesis is commonly induced by growing preadipo-
cyte cells such as OP9 or 3T3-L1 cells to confluency and then
applying an adipogenic mixture consisting of insulin, fetal bovine
serum (FBS), dexamethasone (dex), which is a synthetic gluco-
corticoid, and 3-isobutyl-1-methylxanthine (IBMX), which is an
inhibitor of phosphodiesterase that increases cAMP levels. After
2days, theglucocorticoidandcAMPstimuli are removed, and the
media are replaced with media containing only insulin and FBS.CWe performed single-cell image analysis of adipogenesis in
both OP9 and 3T3-L1 cells (Figures 1B and S1A). Cells were
plated in 96-well plates, induced to differentiate by the addition
of insulin, glucocorticoid, and cAMP stimuli, fixed at different
time points after induction, and stained with antibodies to
quantify the expression level of the key adipogenic transcription
factors. When we averaged the resulting antibody intensities
from cells fixed at each day of adipogenesis, we observed a
sequential order of events, similar to previously published
western blot results by Farmer (2006). In both OP9 cells and
3T3-L1 cells, maximal average C/EBPb expression occurred
1–2 days after the induction of adipogenesis, preceding the
induction of maximal PPARg and C/EBPa expression, and fol-
lowed after a delay by maximal lipid droplet formation (Figures
1C and S1B).
Bimodal Induction of PPARg, C/EBPa, and C/EBPb
To further explore the relationship between the transcription
factors, we carried out single-cell, multiparameter analysis (Fig-
ure S1C). In contrast to analysis of population averages, histo-
grams that plotted the concentration of the transcription factors
in each of approximately 25,000 single cells showed bimodal
expression of PPARg, C/EBPa, and C/EBPb, starting at day 3
of adipogenesis even though the cells had been uniformly stim-
ulated (Figure 1D). Just as separating proteins out on a two-
dimensional gel results in better resolution than separating in
a one-dimensional gel, using two parameters to plot the histo-
grams better resolved the bimodal nature of the transcription
factor induction. Each of the panels in Figure 1E shows a dual-
parameter histogram analysis that plotted the frequency at
each day of differentiation at which individual cells had a given
concentration of PPARg and C/EBPb. At day 0, all the cells
had low PPARg and low C/EBPb. At days 1 and 2, the cells
had slightly higher PPARg and significantly higher C/EBPb than
at day 0. At day 3, two populations of cells were clearly evident,
indicating that sometime between days 2 and 3, a subpopulation
of cells reverted back into a low PPARg and low C/EBPb state,
whereas a second kept increasing their high PPARg and high
C/EBPb level. Strikingly, this transition into the high PPARg
and high C/EBPb state occurred early in adipogenesis, 1 day
before accumulation of lipid, which is the usual marker of
terminal differentiation.
Our population-averaged results shown in Figure 1C initially
suggested that for adipogenesis to occur, C/EBPb expression
first drops at day 2 to about half before PPARg and C/EBPa
reach maximal expression (Yeh et al., 1995). However, single-
cell analysis led to a different conclusion (Figure 1E, schematics).
After removal of the glucocorticoid and cAMP stimuli, the
expression of both C/EBPb and PPARg further increased in
a fraction of cells, whereas in the remaining cells, the expression
of both C/EBPb and PPARg dropped back to basal in both OP9
(Figure 1E) and 3T3-L1 cells (Figure S1D). Thus, even though all
cells experienced the same differentiation-inducing stimulus,
this remarkable switch behavior resulted in two groups of cells
with distinct levels of PPARg and C/EBPb and with increasing
amounts of differentiation inducers resulting in increasing
numbers of cells in the high PPARg-high C/EBPb differentiated
cell group (Figure S1E). This bifurcation suggested that eachell Reports 2, 976–990, October 25, 2012 ª2012 The Authors 977
Figure 1. Testing for the Existence of
Distinct Cell Differentiation States
(A) Current model of adipogenesis is shown.
(B) Development of a single-cell approach to mea-
sure expression of key transcription factors
and lipid accumulation over the time course of
adipogenesis is illustrated. Immunohistochem-
istry staining of OP9 cells using specific anti-
bodies to visualize PPARg, C/EBPa, and C/EBPb
(red), BODIPY 493/503 to visualize lipid droplets
(green), and Hoechst to visualize nuclei (blue) is
presented. Scale bar, 40 mm.
(C) PPARg, C/EBPa, and C/EBPb concentrations
were obtained by averaging intensities of antibody
staining from the nuclei of individual cells (right).
Total cellular lipid droplet content was obtained by
averaging BODIPY intensities from the cytosol of
individual cells (left). Approximately 25,000 cells
were used for each time point. Error bars show SE
calculated from three independent experiments.
All values are normalized to the respective
average day 0 (unstimulated) values. Rel. Protein
Intensity, relative protein intensity; Rel. BODIPY
Intensity, relative BODIPY intensity.
(D) Histograms show number of cells (y axis) with
the specified concentrations of PPARg, C/EBPa,
or C/EBPb (x axis). Approximately 25,000 cells
were used for each histogram.
(E) 3D histograms show number of cells (z axis)
with the specified relative nuclear concentrations
of C/EBPb (x axis) and PPARg (y axis). Approxi-
mately 7,000 cells were used for each histogram.
Right bottom shows a schematic of the decision
process. Int., intensity.
See also Figure S1.cell undergoes an all-or-none cell fate decision to either commit
to differentiation or to revert to the low PPARg-low C/EBPb
preadipocyte state.
PPARg Is Regulated by Two Positive Feedbacks
to C/EBPa and to C/EBPb
To enable the existence of two stable states, a system typically
requires positive feedback, as well as one or more cooperative978 Cell Reports 2, 976–990, October 25, 2012 ª2012 The Authorsregulatory steps. Figure 2A shows a
schematic representation of how positive
feedback canhelp create suchadecision.
In the simplest case of positive feedback,
the change in x is linearly related to the
amount of y and vice versa. At steady-
state conditions, the curves representing
the dependence of x on y (blue line) and y
on x (red line) will intersect at two points:
one stable, and one unstable (Figure 2A,
middle panel). If y is instead cooperatively
related to x, for example if y is a gene that
is only transcribed when three binding
sites for transcription factor X in its
promoter are occupied, this cooperative
relationship can be described by a Hill
equation and plotted as a sigmoidal curve(Figure 2A, right panel, red line).With this added cooperativity the
curves representing the dependence of x on y (blue line) and y
on x (red line) will now intersect at three points at steady-state
conditions: two stable states and one unstable state. Positive
feedback ensures that the system cannot rest in intermediate
states, and cooperativity filters small signals out, allowing the
system to have a stable off as well as a stable on-state (Ferrell
and Xiong, 2001).
We first confirmed that a previously described positive feed-
back loop exists between PPARg and C/EBPa (Rosen et al.,
2002; Wu et al., 1999) by siRNA-mediated knockdown of PPARg
and C/EBPa expression, which reduced the expression of
C/EBPa and PPARg, respectively (Figure 2B, left and middle
panels). However, one feedback loop—unless highly coopera-
tive—is not enough to generate a bistable switch (Brandman
and Meyer, 2008). We therefore searched for other potential
feedback loops that could contribute to the bimodal patterns
observed in Figure 1. As expected because C/EBPb has been
shown to act upstream of PPARg (Yeh et al., 1995), knockdown
of C/EBPb reduced PPARg expression (Figure 2B, left panel).
However, when we used siRNA to suppress PPARg expression,
we found, especially at days 3 and 4, that C/EBPb expression
was also markedly reduced (Figure 2B, right panel), arguing
that PPARg was able to regulate the expression of its upstream
activator C/EBPb and suggesting that a second positive feed-
back links PPARg and C/EBPb. The existence of such a feed-
back loop is also supported by promoter binding studies that
showed interactions of C/EBPb with the PPARg promoter
(Schmidt et al., 2011) and of PPARg with the C/EBPb promoter
(Mikkelsen et al., 2010).
Our siRNA data showed that this feedback loop between
PPARg and C/EBPb engaged only 3–4 days after induction of
adipogenesis, providing an important second boost to C/EBPb
expression. This suggested that a main role of this feedback is
to keep C/EBPb levels high after 48 hr independently of the initial
glucocorticoid receptor (GR) and cAMP stimulation. This positive
feedback between PPARg and C/EBPb therefore has the char-
acteristics of a stabilizing switch mechanism that keeps PPARg
and C/EBPb autonomously high even after the initiating stimulus
is removed.
To confirm the existence of a positive feedback fromPPARg to
C/EBPb by a second independent method, we used the PPARg
activators rosiglitazone and pioglitazone to directly activate
endogenous PPARg in the absence of other stimuli (Willson
et al., 2001) (Figure 2C). Addition of both activators induced
amarked upregulation of C/EBPb (Figure 2C, right panel). Finally,
we also overexpressed PPARg using retroviruses to confirm that
increasing PPARg expression resulted in increased C/EBPb
expression. The images of the single-cell analysis, as well as a
quantitative scatterplot of the single-cell results, show significant
correlation between PPARg and C/EBPb expression (Figure 2D).
We also confirmed the existence of the PPARg-C/EBPb feed-
back loop in the 3T3-L1 cell model (Figure S2D), which argued
that this second feedback loop is a general mechanism for
driving adipogenesis. Thus, as depicted in the scheme in Fig-
ure 3A, two consecutive positive feedback loops generate
a bimodal distribution of high or low PPARg, C/EBPb, and
C/EBPa activity early in adipogenesis.
Consecutive and Cooperative Induction of the
PPARg-C/EBPa Followed by the PPARg-C/EBPb
Positive Feedback Loops
The existence of feedback loops from PPARg meant that we
could trigger the expression of C/EBPb, C/EBPa, and PPARg
just by adding a PPARg activator, without needing glucocorti-
coids or increased cAMP. To determine whether the regulatoryCsteps that initially induce the expression of PPARg, C/EBPa,
andC/EBPbwere cooperative, aswould be predicted for a bista-
ble system, we titrated the PPARg activator rosiglitazone into the
media of undifferentiated OP9 cells and monitored the resulting
protein expression levels after 48 hr (Figure 3B), a time point at
which all three transcription factors showed maximal expression
(Figure 2C). Consistent with the existence of a cooperative step
in the induction of C/EBPb, C/EBPa, and PPARg, the stimulus-
response curves all had sigmoidal shapes that could be best fit
with Hill coefficients of 2.5.
Interestingly, the half-maximum response (EC50) for C/EBPb
expression was 4-fold higher than that for C/EBPa expression,
indicating that the PPARg-C/EBPb feedback loop has a higher
threshold for activation than the PPARg-C/EBPa feedback
loop. Because it takes time to build up the level of PPARg,
the positive feedback loop between PPARg and C/EBPb would
be predicted to then engage with a delay after the PPARg to
C/EBPa loop. We confirmed that there is indeed a marked delay
between engagement of the PPARg-C/EBPa and PPARg-
C/EBPb feedback loops. Western blot analysis performed at
different time points after treatment with rosiglitazone showed
that C/EBPa expression reached a maximal level within 24 hr
(Figure 3C). However, maximal C/EBPb expression was reached
only after 72 hr.
Our analysis introduces a regulatory motif whereby a first
feedback loop has to be engaged for a prolonged time period
in order for a second feedback to be triggered that then carries
the differentiation commitment process forward. A plausible
result of such a second amplification by the PPARg-C/EBPb
feedback loop is to create a sharper transition to the differenti-
ated state. Indeed, when we used siRNA against C/EBPb to
suppress the second PPARg-C/EBPb feedback loop, the transi-
tion from low to high PPARg expression with increasing amounts
of rosiglitazone was more gradual and less robust compared to
the sharp transition in the cells transfected with control YFP
siRNA (Figure 3D). With the PPARg-C/EBPb feedback loop sup-
pressed, a large population of the cellswas unable to transition to
the high PPARg state, evenwhenmaximal doses of rosiglitazone
were applied (Figure S3). Similar to other systems with multiple
positive feedback loops (Brandmanet al., 2005), the higher coop-
erativity generated by two consecutive feedback loops gives
cells a stable off, as well as on, state (as described in Figure 2A).
The stable off-state allows cells to reject short- or low-amplitude
stimuli, which provides one of the keymechanistic ingredients for
a sharp, all-or-none transition to a committed on-state.
To understand the respective roles of the different feedback
loop components, we performed detailed siRNA-mediated
perturbation experiments. Knockdown of C/EBPa resulted in an
almost-complete suppression of PPARg expression (Figure 3D),
confirming that the PPARg-C/EBPa feedback loopwas essential
for PPARg expression (Rosen et al., 2002). Knockdown of C/
EBPa also resulted in almost-complete knockdown of C/EBPb
expression (Figure 3E), showing that the PPARg-C/EBPb feed-
back loop required the presence of a functioning PPARg-C/
EBPa feedback loop and arguing for the sequential induction
model depicted in Figure 3F: (1) cAMP and glucocorticoid signals
initially drive C/EBPb expression; (2) increasing C/EBPb above
a critical threshold then triggers the start of a positive feedbackell Reports 2, 976–990, October 25, 2012 ª2012 The Authors 979
Figure 2. Identification of a Positive Feedback Loop between PPARg and C/EBPb
(A) The left view is a schematic of a feedback loop between two variables x and y. The middle view is steady-state plots (dx/dt = 0 is in blue; dy/dt = 0 is in red)
where the feedback loop from x to y and the feedback loop from y to x are both linear. When the feedback loops are both linear, there is only one stable steady
980 Cell Reports 2, 976–990, October 25, 2012 ª2012 The Authors
Figure 3. Characterization of the PPARg-
C/EBPb and PPARg-C/EBPa Feedback
Loops
(A) Diagram shows the here-identified feedback
loop between PPARg and C/EBPb in red.
(B) PPARg, C/EBPa, and C/EBPb expression in
OP9 cells in response to increasing concentra-
tions of rosiglitazone is illustrated. All values were
normalized to basal values (without rosiglitazone).
(C) One micromolar of rosiglitazone was added to
the media of undifferentiated OP9 cells, and the
cells were harvested at the indicated times. Then
equal amounts of each protein sample were sub-
jected to western blot analysis.
(D and E) 20 nMof YFP (control), C/EBPb, C/EBPa,
or PPARg siRNA was transfected into undifferen-
tiated OP9 cells 24 hr prior to adding rosiglitazone.
Cells were fixed 48 hr after adding rosiglitazone. All
values are normalized to the value of YFP siRNA-
transfected cells without rosiglitazone. For (B), (D),
and (E), protein expression was quantified by
immunohistochemistry stainingof the cellswith the
respective specific antibodies and then imaging.
Each data point represents 20,000 cells (mean ±
SD of three replicate wells).
(F) Diagram shows the sequential order of steps
that trigger the bistable switch.
See also Figure S3.between PPARg and C/EBPa that, after a time delay; (3) induces
the second PPARg-C/EBPb feedback loop so that most of the
cells transition into a terminally differentiated state. However,
there was always a fraction of cells falling back to the basal state
(Figure 1E), raising the question how cells regulate which fraction
becomes locked in the differentiated state.state (black dot) and one unstable steady state (green dot). The right view is steady-state plots indicating whe
but now the feedback loop from y to x is highly cooperative (red). In this case there are two stable steady st
(B) OP9 cells were transfected with siRNA (20 nM) and 24 hr later were stimulated to differentiate with insulin
normalized to the YFP (control) value at each time point.
(C) Activating PPARg with small molecules results in increased C/EBPa and C/EBPb expression. Rosig
(control) was added to themedia of undifferentiated OP9 cells. For (B) and (C), the cells were fixed at the respe
C/EBPa, and C/EBPb, and analyzed by epifluorescencemicroscopy. Each bar represents approximately 20,0
replicate wells).
(D) Overexpression of C/EBPa or PPARg by retroviral infection resulted in expression of C/EBPb in the co
transfection, costained with specific antibodies to PPARg and C/EBPb, and analyzed by epifluorescence mic
between C/EBPb expression versus PPARg expression are demonstrated. Lower panels show represent
C/EBPb (green), and PPARg (red). Scale bars, 50 mm.
See also Figure S2.
Cell Reports 2, 976–990,Characterization of a Late-Acting,
Third Positive Feedback Loop
between PPARg and the Insulin
Pathway
We observed that upregulating PPARg
activity increased insulin receptor
expression (Figure 4A), which was not
surprising since an earlier study had
shown that C/EBPa can regulate insulin
receptor expression and PPARg and C/
EBPa are in a positive feedback loop(Wu et al., 1999). To test whether the converse were true—that
the insulin pathway could regulate PPARg expression, thus
creating a third feedback loop from PPARg via C/EBPa—we
used siRNA to knock down insulin receptor expression and
carried out the standard adipocyte differentiation protocol.
Indeed, insulin signaling is required to increase PPARgre the feedback loop from x to y is still linear (blue),
ates and one unstable steady state.
, glucocorticoid, and cAMP stimuli. All values were
litazone (10 mM), pioglitazone (10 mM), or DMSO
ctive time points, stained with antibodies to PPARg,
00 cells from four separate wells (mean ±SD of four
rresponding cells. Cells were fixed 10 days after
roscopy. Scatterplots representing the correlation
ative immunofluorescent staining of nuclei (blue),
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Figure 4. Characterization of a Third, Late-
Acting Feedback Loop between PPARg
and the Insulin Pathway
(A) Time course of PPARg and insulin receptor (IR)
expression in OP9 cells in response to rosiglita-
zone addition is presented.
(B) 20 nM of glucocorticoid receptor (GR), IR, or
control (YFP, GL3) siRNA was transfected into
undifferentiated OP9 cells that were, 24 hr later,
stimulated to differentiate. C/EBPb and PPARg
expression levels were measured by single-cell
immunohistochemistry using specific antibodies.
Each bar represents 7,000 single cells (mean ± SD
of four replicate wells). All values were normalized
to the value of the YFP siRNA-transfected cells at
day 0.
(C) Western blot shows IRb expression over the
time course of adipogenesis.
(D) Histograms show number of cells (y axis) with
the specified concentrations of PPARg (x axis)
with 175 nM insulin or without insulin at day 3.
(E) Histograms show number of cells (y axis) with
the specified concentrations of pAKT (x axis).
Approximately 25,000 cells were stained with
pAKT(S473) antibody and analyzed for each
histogram.
(F) Scatterplot shows concentrations of BODIPY
versus PPARg or p-AKT in 7,000 individual OP9
cells 96 hr after the induction of adipogenesis. As
shown in the inset bar plot, cells at the center of
the high PPARg population (box labeled ‘‘2’’) had
an 33 higher average BODIPY intensity than
cells at the center of the low PPARg population
(box labeled ‘‘1’’).
For (B–F), undifferentiated OP9 cells were induced
to differentiate by adding the adipogenic cocktail
for 2 days and then replacing the medium with
fresh growth medium containing 175 nM insulin
and 10% FBS.
See also Figure S4.expression 2-fold between days 2 and 3 (Figure 4B). However,
during the first 2 days of adipogenesis, insulin signaling has
only a small effect on C/EBPb and PPARg expression (Figures
4B and S4A), most likely due to the fact that the insulin receptor
is strongly expressed only after day 2 (Figure 4C). As a control in
the siRNA experiments, knockdown of the GR, which is needed
to start differentiation, suppressed C/EBPb and PPARg expres-
sion already at day 1 (Figure 4B). These results confirm the exis-
tence of a third feedback loop between PPARg and the insulin
receptor that only engages with a delay after the induction of
the C/EBPb-PPARg-C/EBPa dual-positive feedback system
(Figures 3C and 4A).
This third feedback loop between PPARg and the insulin
pathway is not needed to trigger the bistable switch as evi-
denced by the fact that the switch triggers regardless if insulin982 Cell Reports 2, 976–990, October 25, 2012 ª2012 The Authorsis added under normal differentiation
induction with glucocorticoids and
cAMP (Figure 4D) and that rosiglitazone
stimulation induces the switch even
though no insulin is added (Figure S3).Furthermore, pAKT levels that can be used to monitor insulin
signaling are never bimodal during adipogenesis (Figure 4E), in
contrast to the bimodal expression of the switch components
C/EBPb, C/EBPa, and PPARg (Figure 1D). As shown in Fig-
ure 4D, the main function of this third feedback loop between
PPARg and the insulin receptor is to amplify and boost
PPARg expression after the switch is made. Thus, the consecu-
tive action of the three positive feedback loops generates
a subpopulation of differentiated cells with persistently high
PPARg levels.
Insulin Signaling Controls Fat Accumulation in
Differentiated Cells in a Graded Fashion
To directly determine the relationship between PPARg expres-
sion and lipid accumulation, we used immunohistochemistry to
measure both parameters in the same individual cells. Because
insulin signaling is a main regulator of adipocyte metabolism,
we further monitored the insulin receptor pathway by measuring
the cellular intensity of p-AKT. The inset plot in Figure 4F (left)
shows that the differentiated population with high PPARg had
on average 3-fold more lipid incorporated than the low PPARg
population, consistent with the interpretation that a persistently
high level of PPARg defines the differentiated adipocyte state.
However, at the single-cell level, fat accumulation correlated
only weakly with relative PPARg expression (Figure 4F, left).
This can be seen by the wide spread of BODIPY intensities
when focusing on cells with high PPARg. Thus, whereas PPARg
drives the differentiation process and marks differentiated cells,
fat accumulation itself must be under control of another signaling
pathway. Strikingly, the degree of lipogenesis in these differenti-
ated cells with high PPARg could be more closely predicted by
the relative activity of p-AKT (Figure 4F, right), arguing that the
strength of insulin-Akt signaling is the main determinant of how
much fat is accumulated in an individual differentiated cell. The
same data further show that this relationship between p-AKT
and fat accumulation is graded, not bistable, which means that
once the switch ismade into the differentiated, high PPARg state
and high levels of insulin receptors are present, there is no
threshold that needs to be overcome to accumulate fat. Weak
insulin stimuli will already cause some fat formation, and
increasing the insulin stimulus will proportionally increase the
amount of fat synthesis in existing adipocytes. Of note, there
was a small fraction of the total cell population that had high
BODIPY intensity (Figure 4F, left), and also high p-Akt, whereas
having low PPARg expression. These cells may have alternative
regulatorymechanisms to increase insulin signaling not involving
PPARg expression.
Development of a Quantitative Molecular Model
of Adipogenesis
We used the data from our single-cell analysis to generate
a quantitative model of the C/EBPb-PPARg-C/EBPa-driven bi-
stable switch, the insulin receptor-mediated PPARg booster
mechanism, and the subsequent insulin-regulated lipogenesis
program. The diagram in Figure 5A illustrates the consecutive
order of the three positive feedback loops that we identified
for PPARg activation (marked as steps 2, 3, and 4, respectively)
and the subsequent insulin control of lipid accumulation (marked
as step 5). Of note, there is likely no direct positive feedback
between C/EBPa and C/EBPb because chromatin immunopre-
cipitation data sets (Schmidt et al., 2011; Siersbæk et al.,
2011) showed no evidence of C/EBPa or C/EBPb binding to
each other’s promoters. In addition we also included in our
model the previously demonstrated inhibition of the insulin
signaling pathway by glucocorticoid and cAMP (Li et al.,
2008), which we confirmed in experiments shown in Figures
S4B–S4E. From a conceptual perspective the adipocyte differ-
entiation system represents a novel design with consecutive
positive feedbacks that engage at different times during the
commitment process, allowing cells to ultimately reach a termi-
nally differentiated state. The model recreates the initial increase
in C/EBPb expression, followed by the upregulation of C/EBPa
and PPARg, that is seen when thousands of single-cellCmeasurements are averaged (Figure 5B, left; reproduced from
Figure 1C).
To take into account that expression levels of regulatory
proteins vary between individual mammalian cells (Niepel
et al., 2009), we added stochastic variations to the relative ampli-
tude of PPARg, C/EBPb, and C/EBPa synthesis, degradation,
and basal expression parameters, respectively. As shown in
Figure 5C when an average of 30% lognormal noise was added
to the parameters, the model replicated the bimodality observed
experimentally in Figure 1E, providing in silico evidence that the
adipogenesis system is inherently bistable. No matter how we
varied the initial parameters and pulled away from median
values, the system always reverted back to one of the two
stable points schematically shown in Figure 2A (right panel),
which represent a stable differentiated and a stable nondifferen-
tiated state.
This same analysis can also be used to estimate differences in
the intrinsic noise among the PPARg, C/EBPa, and C/EBPb
parameters. A best match was observed when PPARg rates
were varied less than the C/EBPb and C/EBPa rates—by an
average of 15% for PPARg compared to 30% for C/EBPb and
C/EBPa, respectively (Figure S5A). The modeling further shows
that if the protein variation would be much smaller, e.g., 3%,
there would not be sufficient variation to create two populations
of cells (Figure S5B). All cells would either remain undifferenti-
ated, or all would switch to the differentiated state as the stim-
ulus increases. On the other hand, if the variation were 100%,
most cells would be in a state where the bistability of the system
would break. The sweet spot in variation where bimodality
is generated without breaking the system is approximately
15%–45%.
Thus, both experiments and modeling demonstrate that
a uniform stimulus can create distinct differentiated and nondif-
ferentiated subpopulations of cells with high versus low PPARg/
C/EBPb concentrations, respectively. This induction of two
clearly separate subpopulations can be explained by stochastic
variation of the expression levels of the key regulatory proteins.
Whether or not a particular ‘‘cell’’ will fall into the low or high
PPARg and C/EBPb subpopulation depends on whether the
relative expression levels of the regulatory proteins position the
cell below or above a system’s threshold where the bistable
switch is triggered. Because they are connected by feedback,
all three regulatory proteins contribute to setting the threshold
of the system. However, consistent with a more central role of
PPARg in controlling the threshold, model calculations showed
that expression of PPARg immediately before the switch is trig-
gered is more predictive of a cell’s subsequent differentiation
state compared to the levels of C/EBPb or C/EBPa (Figure S5C).
Multiple Consecutive Positive Feedbacks Are Required
to Create an Irreversible, Committed Differentiation
State
We next tested whether the model reproduces our earlier
observation in Figures 4B and 4D that the initial glucocorticoid
and cAMP stimulation is sufficient to lock the system into
a committed state even without the third positive feedback to
the insulin receptor. The output of these simulations shows
that PPARg, C/EBPa, and C/EBPb stayed high even after theell Reports 2, 976–990, October 25, 2012 ª2012 The Authors 983
Figure 5. Development of a First Quantitative Molecular Model of Adipogenesis
(A) The left view is a diagram depicting the sequence of steps leading to a terminally differentiated fat cell and subsequent accumulation of lipid. The dashed lines
show the activating and inhibiting roles of cAMP and glucocorticoids (see also Figures S4B–S4E). The heavy, double-lined black arrows indicate that lipogenesis
is much more strongly correlated with p-AKT activity than with PPARg expression. The model equations are shown on the right.
(B) Output of the model compared to the experimental data from Figure 1B is presented.
(C) Stochastic variation in the rates of C/EBPb, C/EBPa, and PPARg expression levels causes two subpopulations of cells to exist even for a uniform stimulation.
See also Figure S5.glucocorticoid and cAMP stimuli were removed after 48 hr,
demonstrating that the switch can be triggered even without
the third positive feedback loop between PPARg and the insulin
receptor (Figure 6A). However, if the second feedback loop
between PPARg and C/EBPb was removed from the model,
PPARg, C/EBPa, and C/EBPb levels fell back down to their initial
low values after glucocorticoid and cAMP stimuli were removed
(Figure 6B). Plotting the steady-state curves (Figure 6B, right)
showed that in a system with just one feedback loop, there is
not much cooperativity, and thus, the steady-state curves do984 Cell Reports 2, 976–990, October 25, 2012 ª2012 The Authorsnot have much sigmoidal bending. As a result, there are very
few points in the parameter space where the steady-state
curves can intersect and where the system can maintain two
stable states.
To experimentally test whether or not a one-feedback loop
model can trigger an irreversible transition, we used siRNA to
knock down the expression of C/EBPb versus control (YFP
siRNA) and then added rosiglitazone to activate the feedback
loops. As shown in Figure 6C, stimulating with rosiglitazone for
24 hr partially increased PPARg. Then when the stimulus was
Figure 6. Consecutive Positive Feedback Is Required to Create an Irreversible, Committed Differentiation State
(A) Schematic, model output, and model equations for the two-feedback loop bistable switch are presented.
(B) Schematic, model output, and steady-state plot for a one-feedback loop system are presented. To generate the steady-state curves, the equations for
d[PPARg]/dt and d[C/EBPa]/dt in the model were set to zero and plotted. Incrementally increasing values of constant C/EBPbwere used to generate each of the
PPARg steady-state curves (red). The C/EBPa steady-state curve is shown in blue.
(C) Experiment to test whether a one-feedback loop system can create a bistable transition. Each histogram represents PPARg nuclear intensities from
approximately 30,000 cells. At time 0, undifferentiatedOP9 cells were stimulatedwith rosiglitazone (Rosi; 10 mM) for 24 hr or left in basal media, thenwashed three
timeswith freshmedium, and then either fixed or placed in freshmediumwithout rosiglitazone for 24 hr and then fixed. For the siRNA experiments, C/EBPb or YFP
siRNA was introduced into OP9 cells by reverse transfection 24 hr before time 0.removed for 24 hr, about half the cells locked into the differenti-
ated, high PPARg state, and the other cells fell back into the
undifferentiated state. However, if the PPARg-C/EBPb is sup-
pressed by siRNA knockdown, many cells could not sufficiently
increase PPARg, and even if they did, the majority fell back into
the undifferentiated state when the stimulus was removed for
24 hr. As we show computationally and experimentally, the
failure to maintain a committed state in a one-feedback loop
system demonstrates why the increased cooperativity provided
by the second positive feedback between PPARg and C/EBPb is
of utmost importance in creating a robust bistable system.CHistory Dependence or Hysteresis of the Positive
Feedback Loops
An important additional characteristic of a predicted bistable
system is hysteresis. Hysteresis can be demonstrated by using
an initial strong stimulus to lift cells into an on-state and then re-
turning the cells to a low stimulus level that had previously kept
the cells in the off-state. If a system has hysteresis, even though
the stimulated cells have returned to a low stimulus level, they do
not turn off. Rather, cells remain stuck in the on-state. A system
with hysteresis thus has biochemical memory, and cells are
capable of ‘‘remembering’’ that they have been stimulatedell Reports 2, 976–990, October 25, 2012 ª2012 The Authors 985
Figure 7. Using a Small Molecular Activator
of PPARg to Demonstrate Hysteresis in the
Circuit Controlling Adipogenesis
(A) A short, high-amplitude pulse of PPARg
activation can lock a fraction of cells in the
differentiated state. At time 0, undifferentiated
OP9 cells were either stimulated with rosiglita-
zone (10 mM) or control (DMSO) for 3 hr, washed
three times with fresh medium, and then placed
in fresh medium without rosiglitazone or DMSO.
Cells were fixed 48 hr after treatment with a
rosiglitazone pulse (red curve) or without a pulse
(blue curve). Each histogram plots the nuclear
PPARg intensities from approximately 20,000
cells.
(B) Increasing the amplitude of the PPARg acti-
vation pulse locks more cells in the differentiated
state. PPARg expression versus rosiglitazone
concentration is shown as a plot where each data
point is the average of approximately 20,000 cells
(±SD of triplicate wells, left) or as the change in
distribution between the low PPARg peak or the
high PPARg peak (right). Two-fold serial dilutions
of rosiglitazone were added to the media of
undifferentiated OP9 cells, and the cells were
fixed 48 hr later. Protein expression was quanti-
fied by immunohistochemistry staining of the cells
with the respective specific antibodies and then
imaging. The horizontal white, blue, and red bar in
the right plot shows the percentage of cells in the
low or the high PPARg peak for a given concen-
tration of rosiglitazone.
(C) A requirement for sustained PPARg helps to
prevent accidental triggering of the bistable
switch. Even after 24 hr of rosiglitazone treatment,
a large fraction of cells can still drop back to the
low PPARg, undifferentiated state when the
stimulus is removed (top plots). Most cells only
lock into the high PPARg, differentiated state after
48 hr of sustained PPARg activity (bottom plots).
See also Figure S6.even though the stimulus has been withdrawn. We observed this
important hysteresis characteristic in our computational adipo-
cyte differentiation model when we applied a transient pulse of
glucocorticoid and cAMP (Figure 6A). Hysteresis was evident
by the sustained elevation of PPARg even after the stimulus
was removed.
Figure 7A shows an experimental test for hysteresis in
response to direct activation of PPARg. A brief 3-hr-long pulse
of PPARg activity induced by adding rosiglitazone to the media,
followed by a return to nonstimulated conditions, was sufficient
to keep a subset of the cells in the high PPARg state even after
the stimulus was removed for almost 48 hr. The blue trace in Fig-
ure 7A is shown as a control where the cells were not subjected
to the pulse of PPARg activity, and no cell converted to the differ-
entiated state even though the PPARg activity was the same
from 3 to 48 hr as for the rosiglitazone-pulsed cells. Figure 7B986 Cell Reports 2, 976–990, October 25, 2012 ª2012 The Authorsshows that the adipogenesis differentia-
tion system is indeed capable of hyster-
esis, meaning that there is a discontin-uous jump from the low-to-high PPARg state. When all the
cells in a well are averaged together, one observes a continuous
sigmoidal curve (Figure 7B, left panel). However, as shown by the
five inset plots in Figure 7B, each point in this curve is actually the
average of a population of cells that is either in the low PPARg
state or high PPARg state. If instead of averaging all the cells,
one plots the percentage of cells in each population as a function
of PPARg activity, the discontinuity in the stimulus-response
relationship becomes apparent with cells being in one of two
possible PPARg intensity states for a given intermediate
stimulus (grey-shaded area in Figure 7B). However, when
maximal rosiglitazone is applied for 48 hr, all cells switch into
the high PPARg state.
Consistent with the existence of hysteresis, increasing the
stimulus duration locks more cells into the high PPARg state
(Figure 7C). When C/EBPa, C/EBPb, and PPARg levels were
monitored in response to PPARg activity pulses ranging from 3
to 48 hr (Figure S6), the fraction of cells that end up in the differ-
entiated state gradually increases. Together with the amplitude
dependence in Figure 7B, these results argue that both, the
amplitude as well as the duration of the activation pulse, jointly
control the probability of a cell transitioning to the high PPARg
differentiation state.
Finally, the observed hysteresis in Figure 7 demonstrates that
the rosiglitazone-induced transition to the high PPARg state
transition does not bypass the bistable switch mechanism
described in Figure 1E but rather induces the same circuit.
Thus, the same bistable consecutive positive feedback circuit
with hysteresis is induced by stimulation either with glucocorti-
coid and cAMP or by direct activation of PPARg, further arguing
that this triple feedback circuit is the core mechanism that
converts preadipocytes to terminally differentiated adipocytes.
DISCUSSION
Three Consecutive Positive Feedbacks Drive
Preadipocyte-to-Adipocyte Differentiation
Our results demonstrate that a commitment decision is made by
preadipocytes early in adipogenesis before the appearance of
lipid droplets, which has been a previous criterion for defining
a terminally differentiated adipocyte state. This commitment
process is bistable rather than graded. We demonstrated that
the commitment decision relies on three consecutive positive
feedback loops: a first loop between C/EBPa and PPARg, fol-
lowedby a second loop betweenPPARg andC/EBPb, and a third
positive feedback between PPARg and the insulin receptor.
Importantly, we found that the second feedback loop back to
C/EBPb only engages at a higher PPARg level. The requirement
for higher PPARg caused a marked delay in the activation of the
PPARg-C/EBPb loop compared to the PPARg-C/EBPa loop. A
third positive feedback loop between PPARg and the insulin
receptor then further boosts PPARg expression and helps to
maintain and consolidate the terminally differentiated state.
This third positive feedback only engages after an additional
delay forced by the need for insulin receptors to be expressed
at a higher level and by cAMP and glucocorticoid suppression
of the insulin signaling pathway, which is only removed late in
the differentiation process (Figure S4). Together, the successive
triggering of three positive feedbacks forces a sequence of pre-
defined events onto the adipocyte differentiation process.
We demonstrated that the same differentiation switch can be
induced by either the glucocorticoid and cAMP-mediated induc-
tion of C/EBPb or, more directly, by the rosiglitazone-mediated
activation of endogenous PPARg. Both stimuli show hysteresis,
have the same bimodality in the induction of the high C/EBPb
and PPARg state, and have the same consecutive order of acti-
vation (Figure 7). The identical consecutive activation by the two
different stimuli argues that the same feedback circuit design is
responsible for the endogenous, as well as drug-induced, differ-
entiation of adipocytes. This has mechanistic implications, sug-
gesting that the same consecutive positive feedback loop circuit
design can be triggered by different physiological or drug-
induced stimuli, arguing that the circuit we identified is the
core module responsible for fat cell differentiation.CThe rosiglitazone experiments in Figure 7 demonstrated that
the PPARg-C/EBPa-C/EBPb bistable switch can sense and
transduce both the duration, as well as the amplitude, of the
activating pulse into differentiating an increasing fraction of
the cells while rejecting weak stimuli. This bistable switch
provides a stable off-state that allows preadipocytes to exist
for long periods of time in an undifferentiated state as long as
the stimuli that activate PPARg stay below a critical threshold
and helps to explain how only a small fraction of adipocytes
are renewed in an adult human every year (Spalding et al.,
2008). In contrast, when the inducing stimuli are above the
threshold, the fraction of cells converted to adipocytes can be
controlled in a graded fashion (over about a factor of 16 in rosi-
glitazone in Figure 7B), allowing for better control of the number
of adipocytes than would be obtained in a system in which all
preadipocytes convert to adipocytes in an all-or-none fashion
once a single critical threshold is crossed.
How can one explain why only a part of the cell population
converts to the differentiated state when stimuli have submax-
imal amplitude and/or duration? If one assumes that the cells
are identical and that differentiation is an all-or-none process
at the level of single cells, all cells should differentiate for stimuli
above a particular threshold value or all cells should remain
undifferentiated for stimuli below that threshold value. As shown
in Figure 7B, there is a range of low-amplitude stimuli where no
differentiation is observed, followed by a range of interme-
diate-amplitude stimuli (shaded in grey) where the fraction of
cells that differentiates increases in a graded fashion, followed
by a range of high-amplitude stimuli where all cells are converted
to the high PPARg differentiated state. How can we reconcile an
all-or-none differentiation switch with the observed graded
response in the grey box? As demonstrated by model calcula-
tions for differentiation induced by glucocorticoid and cAMP
stimuli (Figure 5C), the partial conversion of a cell population
can be explained by cell-to-cell variability in expression levels
of regulatory components, which results in variable sensitivity
to PPARg within an otherwise homogenous population of cells.
Thus, for a given submaximal stimulus concentration, some cells
will convert to the high PPARg state sooner than others. The
same fractional conversion also applies to increases in the dura-
tion of maximal stimuli (Figure S6).
Together, these results argue that organisms employ a system
that combines consecutive positive feedback and stochastic
variation and then use both the amplitude and the duration of
the activating stimulus to control the number of differentiated
adipocytes. The demonstrated requirement for persistent and
strong inductive signals confers robustness to the system by
preventing short- and low-amplitude stimuli from accidentally
triggering differentiation.
Graded Control of Fat Accumulation in Individual
Differentiated Adipocytes by Insulin
A consequence of this irreversible commitment step early in
differentiation is that cells must exist that are already committed
to becoming fat cells but do not yet have a visible increase in fat
storage. Once they switch into the persistently high PPARg
state, these differentiated adipocytes control the degree of lipo-
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correlating with the strength of insulin pathway activity in each
cell (p-AKT; Figure 4). In contrast the relative level of PPARg,
which can vary in the differentiated cells, only weakly correlates
with fat accumulation. Thus, two important regulatory programs
need to be distinguished in the management of the weight of
mammals: the regulation of the degree of fat storage in individual
adipocytes, and the total number of adipocytes per organism.
This total number of adipocytes changes only slowly with about
10% turnover per year in humans (Spalding et al., 2008). Our
study then argues that a primary role for the insulin pathway is
to directly control howmuch fat is stored in individual cells rather
than regulating the differentiation decision. In contrast, the differ-
entiation decision, which controls the number of fat cells, is
under a mixed control of glucocorticoid and cAMP stimuli with
only a minor contribution from insulin signaling.
A Computational Molecular Model for Adipocyte
Differentiation
In order to mechanistically understand the differentiation
regulatory circuit, we developed a computational model for the
conversion of preadipocytes to adipocytes. Specifically, our
goals inmodelingwere to (1) learnmoreaboutwhycellsuseacon-
secutive multipositive feedback circuit design to control differ-
entiation, and (2) understand our experimental observation of
bimodality and howsubmaximal stimuli could convert only a frac-
tion of stimulated preadipocytes to adipocytes. As a third, more
long-term goal, we were interested to use differentiation models
to predict which regulatory inputs are best suited as drug targets
to regulate the total number of human adipocytes.
We showed that a single positive feedback loop with low co-
operativity can amplify signals but cannot generate the observed
robust bistability. The experimentally identified consecutive
feedbacks make the differentiation process more nonlinear
(ultrasensitive) and the switch more robust. Our model explains
and quantitatively recapitulates how these sequential feedback
loops are engaged to drive the preadipocytes into a persistent
state characterized by elevated PPARg, C/EBPa, C/EBPb, and
insulin receptor expression. This example of a differentiation
process provides a conceptual framework that a sequential
positive feedback circuit design is well suited to induce a robust
transition to a differentiated state. It is suggestive to propose that
similar consecutive positive feedback circuit designs drive
many, if not most, other differentiation processes.
Our model further demonstrated how stochastic variations in
the expression levels of C/EBPb, C/EBPa, and PPARg cause
a differentiating and nondifferentiating population to coexist
even though all cells are subjected to the same stimuli. This
finding from the model can explain in molecular terms why inter-
mediate stimuli only convert a fraction of preadipocytes into
differentiated cells rather than generating potentially undesir-
able and misfunctioning partially differentiated cells. This
single-cell variation concept also provides a molecular explana-
tion of how organisms can have robust, all-or-none conversion
of individual preadipocyte cells into adipocytes, whereas at
the same time ensuring that the total population of preadipo-
cytes does not convert in an all-or-none fashion for intermediate
stimuli. Rather, single-cell variation ensures that only a small
fraction of the total preadipocyte population converts everyday988 Cell Reports 2, 976–990, October 25, 2012 ª2012 The Authorsto an irreversible, differentiated adipocyte state (Spalding et al.,
2008).
Finally, understanding if, when, andwhere a clear commitment
decision is made by preadipocytes is critical for knowing how to
target therapeutics tomanipulate the differentiation process as a
possible means to treat obesity, diabetes, and other adipocyte-
associated diseases. Because the signaling and transcriptional
network controlling adipogenesis involves multiple feedbacks
with different time constants, it cannot be readily understood
by a graphical diagram alone. We argue that our quantitative
molecular working model of adipogenesis can be used to
guide experiments, to conceptually understand the induction
process, and also to have a newway to test the effect of different
inputs and perturbations to components in the network. As an
example of such a use of the model to predict outcomes, our
experiments in Figure 7 confirmed the prediction from the model
that direct activation of PPARg by rosiglitazone should induce
the bistable switch with coinduced C/EBPa, PPARg, and
C/EBPb expression rather than bypassing the switch and
directly regulating the adipogenesis-relevant genes downstream
of PPARg. The latter could have been predicted with equal plau-
sibility. Instead, our study demonstrated that direct PPARg acti-
vation by rosiglitazone triggers the same consecutive positive
feedback circuit that is triggered by glucocorticoid and cAMP
signaling. The ability of the model to predict drug action exem-
plifies a future use of such differentiation models to predict
optimal combinations of potential therapeutic interventions to
control the total number of adipocytes in a patient by increasing
or decreasing the rate of differentiation from preadipocytes to
adipocytes.
Conclusions
Because of low cooperativity in typical single transcriptional
feedback loops, multiple feedback loops are required in adipo-
genesis to generate sufficient cooperativity to reliably convert
to the differentiated state. Importantly, the circuit design identi-
fied here with consecutive positive feedback loops, including
one that reaches back to C/EBPb, ensures that the differentiation
decision is not triggered accidentally by uncoordinated or brief
and low-amplitude hormonal stimuli. Our model and experi-
mental analysis further show how stochastic variation in the
expression of regulatory proteins is sufficient to explain how
a submaximal stimulus triggers an all-or-none terminal differen-
tiation of only a fraction of proliferating precursor cells. Together,
our study provides conceptual insights into the adipogenesis
process that likely applies to many, if not most, cell fate
decisions.
EXPERIMENTAL PROCEDURES
Cell Culture, Differentiation, Transfection, Antibodies, andPlasmids
OP9 and 3T3-L1 cells were cultured according to the protocols in Wolins et al.
(2006). OP9 cells were grown in growth medium consisting of MEM-a, 2 mM
l-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin, plus 20% FBS.
3T3-L1 cells were grown in 3T3-L1 propagation medium: DMEM with 10%
bovine calf serum, 2 mM l-glutamine, 100 U/ml penicillin, and 100 mg/ml
streptomycin. To induce differentiation, confluent cells were treated with
a differentiation medium containing growth medium plus the standard adipo-
genic cocktail (DIM): 1 mM dex, 175 nM insulin, 0.5 mM IBMX, and 10% FBS.
After 48 hr, the differentiation medium was replaced with growth medium, plus
175 nM insulin and 10% FBS. Diced pool siRNA was generated as previously
described by Galvez et al. (2007) and transfected into OP9 cells using RNAi-
Max (Invitrogen) and a reverse-transfection protocol. DNA transfection was
carried out by retroviral infection. siRNA specificity was verified using a second
diced pool of siRNA, as well as with synthetic siRNA (see Figures S2A–S2C).
Sources for antibodies, reagents, constructs, and primers are provided in
the Extended Experimental Procedures.
Automated Image Acquisition and Processing
Images were acquired on an ImageXpress 5000A automated epifluorescence
microscope (Molecular Devices, Sunnyvale, CA, USA) using a 4X Plan
Fluor objective and a 1,280 3 1,024 pixel, cooled CCD camera with a 12-bit
readout. Image analysis was performed using custom software written in
MATLAB. In brief, nuclear centroids were identified in images of Hoechst stain.
A nucleus mask was generated for each cell by expansion from the centroid to
reach 30% of maximum intensity. A cell mask was then generated by expan-
sion of the nucleus mask 7 mm to include both the nucleus and the perinuclear
region. After local background subtraction, the nucleus mask was used to
measure PPARg, C/EBPb, and C/EBPa mean intensities, and the cell mask
was used to measure BODIPY (lipid droplet content) and p-AKT mean
intensities.
Computational Model
MATLAB SimBiology was used to program and run themodel simulations. The
model equations used to generate Figures 5B and 5C are presented below.
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